0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Virtual Drug Discovery Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-20D14369
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Virtual Drug Discovery Service Market Research Report 2023
BUY CHAPTERS

Virtual Drug Discovery Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-20D14369
Report
October 2024
Pages:128
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Virtual Drug Discovery Service - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Virtual Drug Discovery Service - Market

Virtual Drug Discovery Service - Market

The global market for Virtual Drug Discovery Service was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Virtual Drug Discovery Service, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Virtual Drug Discovery Service by region & country, by Type, and by Application.
The Virtual Drug Discovery Service market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Virtual Drug Discovery Service.
Market Segmentation

Scope of Virtual Drug Discovery Service - Market Report

Report Metric Details
Report Name Virtual Drug Discovery Service - Market
CAGR 5%
Segment by Type:
  • Structure-based Virtual Screening (SBVS)
  • Ligand-based Virtual Screening (LBVS)
  • Others
Segment by Application
  • Biotech and Pharmaceutical Companies
  • Academic Institutions
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Profacgen, CD ComputaBio, Creative Biolabs, BOC Sciences, Jubilant Biosys, MedChemExpress (MCE), HitGen, TargetMol Chemicals, WuXi AppTec, LeadBuilder - Domainex, CSNpharm, ChemNavigator, CKTTDB, Molinspiration, Molsoft, Southwest Research Institute
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Virtual Drug Discovery Service manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Virtual Drug Discovery Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Virtual Drug Discovery Service in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Virtual Drug Discovery Service - Market report?

Ans: The main players in the Virtual Drug Discovery Service - Market are Profacgen, CD ComputaBio, Creative Biolabs, BOC Sciences, Jubilant Biosys, MedChemExpress (MCE), HitGen, TargetMol Chemicals, WuXi AppTec, LeadBuilder - Domainex, CSNpharm, ChemNavigator, CKTTDB, Molinspiration, Molsoft, Southwest Research Institute

What are the Application segmentation covered in the Virtual Drug Discovery Service - Market report?

Ans: The Applications covered in the Virtual Drug Discovery Service - Market report are Biotech and Pharmaceutical Companies, Academic Institutions, Others

What are the Type segmentation covered in the Virtual Drug Discovery Service - Market report?

Ans: The Types covered in the Virtual Drug Discovery Service - Market report are Structure-based Virtual Screening (SBVS), Ligand-based Virtual Screening (LBVS), Others

1 Market Overview
1.1 Virtual Drug Discovery Service Product Introduction
1.2 Global Virtual Drug Discovery Service Market Size Forecast
1.3 Virtual Drug Discovery Service Market Trends & Drivers
1.3.1 Virtual Drug Discovery Service Industry Trends
1.3.2 Virtual Drug Discovery Service Market Drivers & Opportunity
1.3.3 Virtual Drug Discovery Service Market Challenges
1.3.4 Virtual Drug Discovery Service Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Virtual Drug Discovery Service Players Revenue Ranking (2023)
2.2 Global Virtual Drug Discovery Service Revenue by Company (2019-2024)
2.3 Key Companies Virtual Drug Discovery Service Manufacturing Base Distribution and Headquarters
2.4 Key Companies Virtual Drug Discovery Service Product Offered
2.5 Key Companies Time to Begin Mass Production of Virtual Drug Discovery Service
2.6 Virtual Drug Discovery Service Market Competitive Analysis
2.6.1 Virtual Drug Discovery Service Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Virtual Drug Discovery Service Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Virtual Drug Discovery Service as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Structure-based Virtual Screening (SBVS)
3.1.2 Ligand-based Virtual Screening (LBVS)
3.1.3 Others
3.2 Global Virtual Drug Discovery Service Sales Value by Type
3.2.1 Global Virtual Drug Discovery Service Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Virtual Drug Discovery Service Sales Value, by Type (2019-2030)
3.2.3 Global Virtual Drug Discovery Service Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Biotech and Pharmaceutical Companies
4.1.2 Academic Institutions
4.1.3 Others
4.2 Global Virtual Drug Discovery Service Sales Value by Application
4.2.1 Global Virtual Drug Discovery Service Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Virtual Drug Discovery Service Sales Value, by Application (2019-2030)
4.2.3 Global Virtual Drug Discovery Service Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Virtual Drug Discovery Service Sales Value by Region
5.1.1 Global Virtual Drug Discovery Service Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Virtual Drug Discovery Service Sales Value by Region (2019-2024)
5.1.3 Global Virtual Drug Discovery Service Sales Value by Region (2025-2030)
5.1.4 Global Virtual Drug Discovery Service Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Virtual Drug Discovery Service Sales Value, 2019-2030
5.2.2 North America Virtual Drug Discovery Service Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Virtual Drug Discovery Service Sales Value, 2019-2030
5.3.2 Europe Virtual Drug Discovery Service Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Virtual Drug Discovery Service Sales Value, 2019-2030
5.4.2 Asia Pacific Virtual Drug Discovery Service Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Virtual Drug Discovery Service Sales Value, 2019-2030
5.5.2 South America Virtual Drug Discovery Service Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Virtual Drug Discovery Service Sales Value, 2019-2030
5.6.2 Middle East & Africa Virtual Drug Discovery Service Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Virtual Drug Discovery Service Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Virtual Drug Discovery Service Sales Value
6.3 United States
6.3.1 United States Virtual Drug Discovery Service Sales Value, 2019-2030
6.3.2 United States Virtual Drug Discovery Service Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Virtual Drug Discovery Service Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Virtual Drug Discovery Service Sales Value, 2019-2030
6.4.2 Europe Virtual Drug Discovery Service Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Virtual Drug Discovery Service Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Virtual Drug Discovery Service Sales Value, 2019-2030
6.5.2 China Virtual Drug Discovery Service Sales Value by Type (%), 2023 VS 2030
6.5.3 China Virtual Drug Discovery Service Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Virtual Drug Discovery Service Sales Value, 2019-2030
6.6.2 Japan Virtual Drug Discovery Service Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Virtual Drug Discovery Service Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Virtual Drug Discovery Service Sales Value, 2019-2030
6.7.2 South Korea Virtual Drug Discovery Service Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Virtual Drug Discovery Service Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Virtual Drug Discovery Service Sales Value, 2019-2030
6.8.2 Southeast Asia Virtual Drug Discovery Service Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Virtual Drug Discovery Service Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Virtual Drug Discovery Service Sales Value, 2019-2030
6.9.2 India Virtual Drug Discovery Service Sales Value by Type (%), 2023 VS 2030
6.9.3 India Virtual Drug Discovery Service Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Profacgen
7.1.1 Profacgen Profile
7.1.2 Profacgen Main Business
7.1.3 Profacgen Virtual Drug Discovery Service Products, Services and Solutions
7.1.4 Profacgen Virtual Drug Discovery Service Revenue (US$ Million) & (2019-2024)
7.1.5 Profacgen Recent Developments
7.2 CD ComputaBio
7.2.1 CD ComputaBio Profile
7.2.2 CD ComputaBio Main Business
7.2.3 CD ComputaBio Virtual Drug Discovery Service Products, Services and Solutions
7.2.4 CD ComputaBio Virtual Drug Discovery Service Revenue (US$ Million) & (2019-2024)
7.2.5 CD ComputaBio Recent Developments
7.3 Creative Biolabs
7.3.1 Creative Biolabs Profile
7.3.2 Creative Biolabs Main Business
7.3.3 Creative Biolabs Virtual Drug Discovery Service Products, Services and Solutions
7.3.4 Creative Biolabs Virtual Drug Discovery Service Revenue (US$ Million) & (2019-2024)
7.3.5 BOC Sciences Recent Developments
7.4 BOC Sciences
7.4.1 BOC Sciences Profile
7.4.2 BOC Sciences Main Business
7.4.3 BOC Sciences Virtual Drug Discovery Service Products, Services and Solutions
7.4.4 BOC Sciences Virtual Drug Discovery Service Revenue (US$ Million) & (2019-2024)
7.4.5 BOC Sciences Recent Developments
7.5 Jubilant Biosys
7.5.1 Jubilant Biosys Profile
7.5.2 Jubilant Biosys Main Business
7.5.3 Jubilant Biosys Virtual Drug Discovery Service Products, Services and Solutions
7.5.4 Jubilant Biosys Virtual Drug Discovery Service Revenue (US$ Million) & (2019-2024)
7.5.5 Jubilant Biosys Recent Developments
7.6 MedChemExpress (MCE)
7.6.1 MedChemExpress (MCE) Profile
7.6.2 MedChemExpress (MCE) Main Business
7.6.3 MedChemExpress (MCE) Virtual Drug Discovery Service Products, Services and Solutions
7.6.4 MedChemExpress (MCE) Virtual Drug Discovery Service Revenue (US$ Million) & (2019-2024)
7.6.5 MedChemExpress (MCE) Recent Developments
7.7 HitGen
7.7.1 HitGen Profile
7.7.2 HitGen Main Business
7.7.3 HitGen Virtual Drug Discovery Service Products, Services and Solutions
7.7.4 HitGen Virtual Drug Discovery Service Revenue (US$ Million) & (2019-2024)
7.7.5 HitGen Recent Developments
7.8 TargetMol Chemicals
7.8.1 TargetMol Chemicals Profile
7.8.2 TargetMol Chemicals Main Business
7.8.3 TargetMol Chemicals Virtual Drug Discovery Service Products, Services and Solutions
7.8.4 TargetMol Chemicals Virtual Drug Discovery Service Revenue (US$ Million) & (2019-2024)
7.8.5 TargetMol Chemicals Recent Developments
7.9 WuXi AppTec
7.9.1 WuXi AppTec Profile
7.9.2 WuXi AppTec Main Business
7.9.3 WuXi AppTec Virtual Drug Discovery Service Products, Services and Solutions
7.9.4 WuXi AppTec Virtual Drug Discovery Service Revenue (US$ Million) & (2019-2024)
7.9.5 WuXi AppTec Recent Developments
7.10 LeadBuilder - Domainex
7.10.1 LeadBuilder - Domainex Profile
7.10.2 LeadBuilder - Domainex Main Business
7.10.3 LeadBuilder - Domainex Virtual Drug Discovery Service Products, Services and Solutions
7.10.4 LeadBuilder - Domainex Virtual Drug Discovery Service Revenue (US$ Million) & (2019-2024)
7.10.5 LeadBuilder - Domainex Recent Developments
7.11 CSNpharm
7.11.1 CSNpharm Profile
7.11.2 CSNpharm Main Business
7.11.3 CSNpharm Virtual Drug Discovery Service Products, Services and Solutions
7.11.4 CSNpharm Virtual Drug Discovery Service Revenue (US$ Million) & (2019-2024)
7.11.5 CSNpharm Recent Developments
7.12 ChemNavigator
7.12.1 ChemNavigator Profile
7.12.2 ChemNavigator Main Business
7.12.3 ChemNavigator Virtual Drug Discovery Service Products, Services and Solutions
7.12.4 ChemNavigator Virtual Drug Discovery Service Revenue (US$ Million) & (2019-2024)
7.12.5 ChemNavigator Recent Developments
7.13 CKTTDB
7.13.1 CKTTDB Profile
7.13.2 CKTTDB Main Business
7.13.3 CKTTDB Virtual Drug Discovery Service Products, Services and Solutions
7.13.4 CKTTDB Virtual Drug Discovery Service Revenue (US$ Million) & (2019-2024)
7.13.5 CKTTDB Recent Developments
7.14 Molinspiration
7.14.1 Molinspiration Profile
7.14.2 Molinspiration Main Business
7.14.3 Molinspiration Virtual Drug Discovery Service Products, Services and Solutions
7.14.4 Molinspiration Virtual Drug Discovery Service Revenue (US$ Million) & (2019-2024)
7.14.5 Molinspiration Recent Developments
7.15 Molsoft
7.15.1 Molsoft Profile
7.15.2 Molsoft Main Business
7.15.3 Molsoft Virtual Drug Discovery Service Products, Services and Solutions
7.15.4 Molsoft Virtual Drug Discovery Service Revenue (US$ Million) & (2019-2024)
7.15.5 Molsoft Recent Developments
7.16 Southwest Research Institute
7.16.1 Southwest Research Institute Profile
7.16.2 Southwest Research Institute Main Business
7.16.3 Southwest Research Institute Virtual Drug Discovery Service Products, Services and Solutions
7.16.4 Southwest Research Institute Virtual Drug Discovery Service Revenue (US$ Million) & (2019-2024)
7.16.5 Southwest Research Institute Recent Developments
8 Industry Chain Analysis
8.1 Virtual Drug Discovery Service Industrial Chain
8.2 Virtual Drug Discovery Service Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Virtual Drug Discovery Service Sales Model
8.5.2 Sales Channel
8.5.3 Virtual Drug Discovery Service Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Virtual Drug Discovery Service Market Trends
    Table 2. Virtual Drug Discovery Service Market Drivers & Opportunity
    Table 3. Virtual Drug Discovery Service Market Challenges
    Table 4. Virtual Drug Discovery Service Market Restraints
    Table 5. Global Virtual Drug Discovery Service Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Virtual Drug Discovery Service Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Virtual Drug Discovery Service Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Virtual Drug Discovery Service Product Type
    Table 9. Key Companies Time to Begin Mass Production of Virtual Drug Discovery Service
    Table 10. Global Virtual Drug Discovery Service Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Virtual Drug Discovery Service as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Virtual Drug Discovery Service Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Virtual Drug Discovery Service Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Virtual Drug Discovery Service Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Virtual Drug Discovery Service Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Virtual Drug Discovery Service Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Virtual Drug Discovery Service Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Virtual Drug Discovery Service Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Virtual Drug Discovery Service Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Virtual Drug Discovery Service Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Virtual Drug Discovery Service Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Virtual Drug Discovery Service Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Virtual Drug Discovery Service Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Virtual Drug Discovery Service Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Virtual Drug Discovery Service Sales Value by Region (2019-2024) & (%)
    Table 27. Global Virtual Drug Discovery Service Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Virtual Drug Discovery Service Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Virtual Drug Discovery Service Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Virtual Drug Discovery Service Sales Value, (2025-2030) & (US$ Million)
    Table 31. Profacgen Basic Information List
    Table 32. Profacgen Description and Business Overview
    Table 33. Profacgen Virtual Drug Discovery Service Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Virtual Drug Discovery Service Business of Profacgen (2019-2024)
    Table 35. Profacgen Recent Developments
    Table 36. CD ComputaBio Basic Information List
    Table 37. CD ComputaBio Description and Business Overview
    Table 38. CD ComputaBio Virtual Drug Discovery Service Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Virtual Drug Discovery Service Business of CD ComputaBio (2019-2024)
    Table 40. CD ComputaBio Recent Developments
    Table 41. Creative Biolabs Basic Information List
    Table 42. Creative Biolabs Description and Business Overview
    Table 43. Creative Biolabs Virtual Drug Discovery Service Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Virtual Drug Discovery Service Business of Creative Biolabs (2019-2024)
    Table 45. Creative Biolabs Recent Developments
    Table 46. BOC Sciences Basic Information List
    Table 47. BOC Sciences Description and Business Overview
    Table 48. BOC Sciences Virtual Drug Discovery Service Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Virtual Drug Discovery Service Business of BOC Sciences (2019-2024)
    Table 50. BOC Sciences Recent Developments
    Table 51. Jubilant Biosys Basic Information List
    Table 52. Jubilant Biosys Description and Business Overview
    Table 53. Jubilant Biosys Virtual Drug Discovery Service Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Virtual Drug Discovery Service Business of Jubilant Biosys (2019-2024)
    Table 55. Jubilant Biosys Recent Developments
    Table 56. MedChemExpress (MCE) Basic Information List
    Table 57. MedChemExpress (MCE) Description and Business Overview
    Table 58. MedChemExpress (MCE) Virtual Drug Discovery Service Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Virtual Drug Discovery Service Business of MedChemExpress (MCE) (2019-2024)
    Table 60. MedChemExpress (MCE) Recent Developments
    Table 61. HitGen Basic Information List
    Table 62. HitGen Description and Business Overview
    Table 63. HitGen Virtual Drug Discovery Service Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Virtual Drug Discovery Service Business of HitGen (2019-2024)
    Table 65. HitGen Recent Developments
    Table 66. TargetMol Chemicals Basic Information List
    Table 67. TargetMol Chemicals Description and Business Overview
    Table 68. TargetMol Chemicals Virtual Drug Discovery Service Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Virtual Drug Discovery Service Business of TargetMol Chemicals (2019-2024)
    Table 70. TargetMol Chemicals Recent Developments
    Table 71. WuXi AppTec Basic Information List
    Table 72. WuXi AppTec Description and Business Overview
    Table 73. WuXi AppTec Virtual Drug Discovery Service Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Virtual Drug Discovery Service Business of WuXi AppTec (2019-2024)
    Table 75. WuXi AppTec Recent Developments
    Table 76. LeadBuilder - Domainex Basic Information List
    Table 77. LeadBuilder - Domainex Description and Business Overview
    Table 78. LeadBuilder - Domainex Virtual Drug Discovery Service Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Virtual Drug Discovery Service Business of LeadBuilder - Domainex (2019-2024)
    Table 80. LeadBuilder - Domainex Recent Developments
    Table 81. CSNpharm Basic Information List
    Table 82. CSNpharm Description and Business Overview
    Table 83. CSNpharm Virtual Drug Discovery Service Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Virtual Drug Discovery Service Business of CSNpharm (2019-2024)
    Table 85. CSNpharm Recent Developments
    Table 86. ChemNavigator Basic Information List
    Table 87. ChemNavigator Description and Business Overview
    Table 88. ChemNavigator Virtual Drug Discovery Service Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Virtual Drug Discovery Service Business of ChemNavigator (2019-2024)
    Table 90. ChemNavigator Recent Developments
    Table 91. CKTTDB Basic Information List
    Table 92. CKTTDB Description and Business Overview
    Table 93. CKTTDB Virtual Drug Discovery Service Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Virtual Drug Discovery Service Business of CKTTDB (2019-2024)
    Table 95. CKTTDB Recent Developments
    Table 96. Molinspiration Basic Information List
    Table 97. Molinspiration Description and Business Overview
    Table 98. Molinspiration Virtual Drug Discovery Service Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Virtual Drug Discovery Service Business of Molinspiration (2019-2024)
    Table 100. Molinspiration Recent Developments
    Table 101. Molsoft Basic Information List
    Table 102. Molsoft Description and Business Overview
    Table 103. Molsoft Virtual Drug Discovery Service Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Virtual Drug Discovery Service Business of Molsoft (2019-2024)
    Table 105. Molsoft Recent Developments
    Table 106. Southwest Research Institute Basic Information List
    Table 107. Southwest Research Institute Description and Business Overview
    Table 108. Southwest Research Institute Virtual Drug Discovery Service Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Virtual Drug Discovery Service Business of Southwest Research Institute (2019-2024)
    Table 110. Southwest Research Institute Recent Developments
    Table 111. Key Raw Materials Lists
    Table 112. Raw Materials Key Suppliers Lists
    Table 113. Virtual Drug Discovery Service Downstream Customers
    Table 114. Virtual Drug Discovery Service Distributors List
    Table 115. Research Programs/Design for This Report
    Table 116. Key Data Information from Secondary Sources
    Table 117. Key Data Information from Primary Sources
    Table 118. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Virtual Drug Discovery Service Product Picture
    Figure 2. Global Virtual Drug Discovery Service Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Virtual Drug Discovery Service Sales Value (2019-2030) & (US$ Million)
    Figure 4. Virtual Drug Discovery Service Report Years Considered
    Figure 5. Global Virtual Drug Discovery Service Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Virtual Drug Discovery Service Revenue in 2023
    Figure 7. Virtual Drug Discovery Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Structure-based Virtual Screening (SBVS) Picture
    Figure 9. Ligand-based Virtual Screening (LBVS) Picture
    Figure 10. Others Picture
    Figure 11. Global Virtual Drug Discovery Service Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 12. Global Virtual Drug Discovery Service Sales Value Market Share by Type, 2023 & 2030
    Figure 13. Product Picture of Biotech and Pharmaceutical Companies
    Figure 14. Product Picture of Academic Institutions
    Figure 15. Product Picture of Others
    Figure 16. Global Virtual Drug Discovery Service Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Virtual Drug Discovery Service Sales Value Market Share by Application, 2023 & 2030
    Figure 18. North America Virtual Drug Discovery Service Sales Value (2019-2030) & (US$ Million)
    Figure 19. North America Virtual Drug Discovery Service Sales Value by Country (%), 2023 VS 2030
    Figure 20. Europe Virtual Drug Discovery Service Sales Value (2019-2030) & (US$ Million)
    Figure 21. Europe Virtual Drug Discovery Service Sales Value by Country (%), 2023 VS 2030
    Figure 22. Asia Pacific Virtual Drug Discovery Service Sales Value (2019-2030) & (US$ Million)
    Figure 23. Asia Pacific Virtual Drug Discovery Service Sales Value by Country (%), 2023 VS 2030
    Figure 24. South America Virtual Drug Discovery Service Sales Value (2019-2030) & (US$ Million)
    Figure 25. South America Virtual Drug Discovery Service Sales Value by Country (%), 2023 VS 2030
    Figure 26. Middle East & Africa Virtual Drug Discovery Service Sales Value (2019-2030) & (US$ Million)
    Figure 27. Middle East & Africa Virtual Drug Discovery Service Sales Value by Country (%), 2023 VS 2030
    Figure 28. Key Countries/Regions Virtual Drug Discovery Service Sales Value (%), (2019-2030)
    Figure 29. United States Virtual Drug Discovery Service Sales Value, (2019-2030) & (US$ Million)
    Figure 30. United States Virtual Drug Discovery Service Sales Value by Type (%), 2023 VS 2030
    Figure 31. United States Virtual Drug Discovery Service Sales Value by Application (%), 2023 VS 2030
    Figure 32. Europe Virtual Drug Discovery Service Sales Value, (2019-2030) & (US$ Million)
    Figure 33. Europe Virtual Drug Discovery Service Sales Value by Type (%), 2023 VS 2030
    Figure 34. Europe Virtual Drug Discovery Service Sales Value by Application (%), 2023 VS 2030
    Figure 35. China Virtual Drug Discovery Service Sales Value, (2019-2030) & (US$ Million)
    Figure 36. China Virtual Drug Discovery Service Sales Value by Type (%), 2023 VS 2030
    Figure 37. China Virtual Drug Discovery Service Sales Value by Application (%), 2023 VS 2030
    Figure 38. Japan Virtual Drug Discovery Service Sales Value, (2019-2030) & (US$ Million)
    Figure 39. Japan Virtual Drug Discovery Service Sales Value by Type (%), 2023 VS 2030
    Figure 40. Japan Virtual Drug Discovery Service Sales Value by Application (%), 2023 VS 2030
    Figure 41. South Korea Virtual Drug Discovery Service Sales Value, (2019-2030) & (US$ Million)
    Figure 42. South Korea Virtual Drug Discovery Service Sales Value by Type (%), 2023 VS 2030
    Figure 43. South Korea Virtual Drug Discovery Service Sales Value by Application (%), 2023 VS 2030
    Figure 44. Southeast Asia Virtual Drug Discovery Service Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Virtual Drug Discovery Service Sales Value by Type (%), 2023 VS 2030
    Figure 46. Southeast Asia Virtual Drug Discovery Service Sales Value by Application (%), 2023 VS 2030
    Figure 47. India Virtual Drug Discovery Service Sales Value, (2019-2030) & (US$ Million)
    Figure 48. India Virtual Drug Discovery Service Sales Value by Type (%), 2023 VS 2030
    Figure 49. India Virtual Drug Discovery Service Sales Value by Application (%), 2023 VS 2030
    Figure 50. Virtual Drug Discovery Service Industrial Chain
    Figure 51. Virtual Drug Discovery Service Manufacturing Cost Structure
    Figure 52. Channels of Distribution (Direct Sales, and Distribution)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Packaging of Effervescent Tablets Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-17Q10023
Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Pre-Clinical Chemistry Testing Device for Laboratory Animal Models Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-8U10163
Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Fast-disintegrating Tablets Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-11I9951
Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Immuno Oncology Assays Kit Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-34H832
Fri Dec 27 00:00:00 UTC 2024

Add to Cart